The 4G/4G plasminogen activator inhibitor-1 genotype is associated with frequent recurrence of acute otitis media

被引:14
作者
Emonts, Marieke
Wiertsema, Selma P.
Veenhoven, Reinier H.
Houwing-Duistermaat, Jeanine J.
Walraven, Vanessa
de Groot, Ronald
Hermans, Peter W. M.
Sanders, Elisabeth A. M.
机构
[1] Erasmus Univ, Med Ctr, Sophia Childrens Hosp, Dept Pediat, Rotterdam, Netherlands
[2] Univ Utrecht, Med Ctr, Dept Pediat Immunol, Utrecht, Netherlands
[3] Spaarne Hosp, Dept Pediat, Hoofddorp, Netherlands
[4] Leiden Univ, Med Ctr, Dept Med Stat, Leiden, Netherlands
[5] Radboud Univ Nijmegen, Med Ctr, Dept Pediat, Nijmegen, Netherlands
关键词
plasminogen activator inhibitor-1; polymorphism; otitis media;
D O I
10.1542/peds.2006-1390
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objectives. Plasminogen activator inhibitor-1 counterregulates cell migration, adhesion, and tissue repair. The PAI1 4G/5G promoter polymorphism has an effect on expression levels of PAI1. After a first acute otitis media episode, children are at increased risk for a next episode. Because the PAI1 4G allele is associated with higher plasminogen activator inhibitor-1 production and, hence, decreased tissue repair, we hypothesize that this allele may contribute to increased recurrence of acute otitis media. Patients and Methods. The PAI1 4G/5G polymorphism was genotyped in 348 Dutch children aged 1 to 7 years who were suffering from recurrent acute otitis media and participating in a randomized, controlled trial and 463 healthy control subjects, representative of the general population. Results. No significant difference in PAI1 genotype distribution between the whole acute otitis media group and control subjects was observed. However, children with the PAI1 4G/4G genotype had an increased risk of more frequent acute otitis media episodes compared with those who were homozygous for the 5G variant, also after correction for cofactors. This finding was attributable to children < 4 years of age. Conclusions. Our findings suggest that the PAI1 4G/4G genotype is associated with an increased risk for the otitis-prone condition, potentially because of impaired healing after a previous otitis media episode.
引用
收藏
页码:E317 / E323
页数:7
相关论文
共 50 条
  • [31] Genotype frequency of plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism in healthy Japanese males and its relation to PAI-1 levels
    Matsubara, Y
    Murata, M
    Isshiki, I
    Watanabe, R
    Zama, T
    Watanabe, G
    Watanabe, K
    Ikeda, Y
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 1999, 69 (01) : 43 - 47
  • [32] Relationship of plasminogen activator inhibitor 1 gene 4G/5G polymorphisms to hypertension in Korean women
    Kim, Kyu-nam
    Kim, Kwang-min
    Kim, Bom-taeck
    Joo, Nam-seok
    Cho, Doo-yeoun
    Lee, Duck-joo
    CHINESE MEDICAL JOURNAL, 2012, 125 (07) : 1249 - 1253
  • [33] Plasminogen Activator Inhibitor 1 4G/5G and-844G/A Variants in Idiopathic Recurrent Pregnancy Loss
    Magdoud, Kalthoum
    Herbepin, Viviana G.
    Touraine, Renaud
    Almawi, Wassim Y.
    Mahjoub, Touhami
    AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2013, 70 (03) : 246 - 252
  • [34] Polymorphism 4G/5G in the plasminogen activator inhibitor-1 (PAI-1) gene is associated with IgE-mediated allergic diseases and asthma in the Czech population
    Bucková, D
    Hollá, LI
    Vácha, J
    ALLERGY, 2002, 57 (05) : 446 - 448
  • [36] 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene in children with systemic meningococcaemia
    Geishofer, G
    Binder, A
    Müller, M
    Zöhrer, B
    Resch, B
    Müller, W
    Faber, J
    Finn, A
    Endler, G
    Mannhalter, C
    Zenz, W
    EUROPEAN JOURNAL OF PEDIATRICS, 2005, 164 (08) : 486 - 490
  • [37] 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene in children with systemic meningococcaemia
    Gotho Geishofer
    Alexander Binder
    Martin Müller
    Bettina Zöhrer
    Bernhard Resch
    Wilhelm Müller
    Jörg Faber
    Adam Finn
    Georg Endler
    Christine Mannhalter
    Werner Zenz
    European Journal of Pediatrics, 2005, 164 : 486 - 490
  • [38] Plasminogen activator inhibitor-1 4G/5G polymorphism in breast cancer patients and its association with tissue PAI-1 levels and tumor severity
    Castelló, R
    España, F
    Vázquez, C
    Fuster, C
    Almenar, SM
    Aznar, J
    Estellés, A
    THROMBOSIS RESEARCH, 2006, 117 (05) : 487 - 492
  • [39] Association of Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G and Apolipoprotein E polymorphisms with risk of Myocardial Infarction in Indian Tamil Population
    Sahana, Nair
    Vivekananda, Budamagunta
    Abinaya, Meenakshisundaram
    Hemapriyanka, S.
    Pournima, Prabhakaran
    Abirami, B. Suruthi
    Devi, A.
    ArulJothi, K. N.
    RESEARCH JOURNAL OF BIOTECHNOLOGY, 2018, 13 (01): : 91 - 98
  • [40] Plasminogen activator inhibitor-1 (PAI-1) content in platelets from healthy individuals genotyped for the 4G/5G polymorphism in the PAI-1 gene
    Nordenhem, A
    Wiman, B
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1997, 57 (05) : 453 - 461